Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1000-0.0600 (-5.17%)
At close: 04:00PM EDT
1.1500 +0.05 (+4.55%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1600
Bid1.0900 x 2000
Ask1.1100 x 4000
Day's range1.0700 - 1.1850
52-week range0.8800 - 5.5300
Avg. volume8,703,401
Market cap212.016M
Beta (5Y monthly)0.80
PE ratio (TTM)N/A
EPS (TTM)-0.6300
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.16
  • Business Wire

    bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SOMERVILLE, Mass., April 11, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of 102,700 restricted stock units ("RSUs") to twelve newly hired employees with a grant date of April 9, 2024 (the "Inducement Grants"). The Inducement Grants are subject to the terms and conditions of award agreements covering the grants and the Company’s 2021 Inducement Plan.

  • Insider Monkey

    bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript

    bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript March 26, 2024 bluebird bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this […]

  • Business Wire

    bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance

    SOMERVILLE, Mass., March 26, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported fourth quarter and annual financial results and business highlights for the year ended December 31, 2023, including recent commercial and operational progress.